Elevated levels of HbA1c, C-peptide, and IGF-1 in lung cancer patients suggest a link with cancer progression and aggressiveness. Diabetes may influence lung cancer development through systemic inflammation and hormonal imbalances. Here, IGF1 is linked to diabetes mellitus.